Skip to main content
Journal of the Endocrine Society logoLink to Journal of the Endocrine Society
. 2024 Nov 22;9(1):bvae208. doi: 10.1210/jendso/bvae208

Social Determinants of Health for Cardiovascular-Kidney-Metabolic Syndrome Among Patients With Diabetes

Kibret Enyew Belay 1,, Yeweyenhareg Feleke 2, Theodros Aberra Alemneh 3, Asteway Mulat Haile 4, Dawit Girma Abebe 5
PMCID: PMC11635457  PMID: 39669651

Abstract

Context

Cardiovascular-kidney-metabolic (CKM) syndrome is a recently introduced term that is a complex disease consisting of cardiovascular disease, renal disease, obesity, and diabetes. The association of social determinants of health (SDOH) with CKM syndrome is not fully known.

Objective

We aimed to assess SDOH affecting CKM syndrome among adult patients with diabetes at follow-up at a tertiary hospital in Ethiopia.

Methods

A cross-sectional hospital-based study was used. Data were collected using a Kobo toolbox and entered into SPSS version 29 for further analysis.

Results

A total of 422 adult patients with diabetes were included in this study. The mean ± SD age of the patients was 54.14 ± 13.74 years. Fifty-two percent of the patients were male. In this study, 52.4% had cardiovascular kidney metabolic syndrome. Male patients (AOR: 1.73; 95% CI, 1.01-2.94), lost to follow-up for more than a year due to lack of money (AOR: 2.69; 95% CI, 1.01-7.22), missed an appointment due to lack of transportation in the past 1 year (AOR: 2.98; 95% CI, 1.21-7.33), were patients with disability (AOR: 1.97; 95% CI, 1.12-3.48), had hypertension (AOR: 3.12; 95% CI, 1.85-5.28), had obesity (AOR: 2.27, 95% CI, 1.17, 4.40), and were in retirement (AOR: 2.12; 95% CI, 1.04-4.30) these being more significantly associated with CKM syndrome.

Conclusion

More than half of patients had CKM syndrome. More attention should be given to SDOH, including male sex, financial constraints, transportation issues, disability, and retirement.

Keywords: cardiovascular kidney metabolic syndrome, diabetes, social determinants of health, Ethiopia


The presence of a combination of cardiovascular, metabolic, and renal disorders in a complex patient with diabetes is known as cardiovascular-kidney-metabolic (CKM) syndrome, which was coined by the American Heart Association in 2023 [1, 2]. In 2018, among 530 747 individuals with type 2 diabetes in the United States, only 6.4% were free of CKM conditions, while 51% had 3 or more [3]. The Atherosclerosis Risk in Communities (ARIC) study found that renal function was independently and significantly associated with sudden cardiac mortality in the general population, underscoring the importance of addressing CKM syndrome [4]. In 2021, diabetes or its complications were estimated to take the lives of approximately 6.7 million adults aged 20 to 79 years, accounting for 12.2% of all deaths globally [5]. Renal hypoperfusion caused by renin-angiotensin-aldosterone system (RAAS) and sympathetic nervous system activation leads to volume overload, cardiac hypertrophy, and fibrosis, as well as poor tubuloglomerular feedback, resulting in renal hypoxia and injury [6]. CKM management includes lifestyle measures, RAAS inhibitors, sodium-glucose cotransporter-2 inhibitors (CREDENCE, DAPA-CKD, EMPA-KIDNEY trials, a meta-analysis of those studies), glucagon-like peptide-1 receptor agonists (FLOW trial), nonsteroidal mineralocorticoid receptor antagonists (FINE-HEART study), and simvastatin and ezetimibe (SHARP trial) [7-16].

Despite those advancements in the management of CKM syndrome, the prevalence of the disease and its severity have increased [2]. Social determinants of health (SDOH), which is described as the economic, environmental, political, and social conditions under which individuals live, may affect these disease conditions [17]. A study from the United States showed that unemployment, low family income, food insecurity, lack of home ownership, and unpartnered status were associated with a significantly higher risk for cardiovascular disease (CVD) death [18]. In the Kidney Early Evaluation Program (KEEP) study, patients without insurance were 82% more likely than those who have insurance to die and 72% more likely to develop end-stage renal disease [19]. Except for individual social factors that address specific disease components of CKM, several evidence gaps exist about screening for comprehensive social needs among patients with CKM syndrome. It is also important to identify social needs to improve CKM health that are effective in resource-limited settings. There has been no published research focused on SDOH and CKM syndrome in Africa.

As a result, the main aim of this study was to identify SDOH that influence CKM syndrome in low-income settings. This study aims to provide critical data regarding SDOH associated with CKM syndrome among patients with diabetes. This study aims to narrow the information gap regarding patients with diabetes and CKM complications. The results of this study will also help develop a module and guideline for assessing SDOH for people with diabetes locally and in similar low- and middle-income countries and develop a strategy to address SDOH.

Materials and Methods

Study Area and Study Design

A hospital-based, cross-sectional study was conducted among patients with diabetes who visited diabetic clinics at Tikur Anbessa Specialized Hospital (TASH), Ethiopia. The hospital is the largest tertiary hospital with clinics practicing at the subspecialty level in each unit. The endocrinology and metabolism unit in the hospital had 4 clinic visits scheduled every week. The average number of patients with diabetes attending the clinic monthly ranges from 800 to 1000. This study was conducted from May 1, 2024, to June 30, 2024.

Population

The source population consisted of all adult patients with diabetes of TASH visiting the endocrinology and metabolism clinic with a diagnosis of diabetes. The study population includes selected adult patients with diabetes of TASH visiting the endocrinology and metabolism clinic with a diagnosis of diabetes and who had an appointment during the study period.

Sample Size and Sampling Technique

There has been no published paper with a similar study focused on SDOH and CKM disease conducted in Ethiopia and low-income countries. Therefore, the sample size for the study was determined using a single population proportion formula from a prevalence of 50%, a statistical significance level of 5% (α = .05), Z α/2 = 1.96, and a margin of error of 5% (d = 0.05). The total sample size was determined by the following formula:

n=(Zα/2)2(P)(1p)d2
n1=(1.96)2×0.5(10.5)0.0025=384

Adding a 10% nonresponders rate, the total sample size was 422. Every consecutive eligible patient was involved in the study until we had an adequate sample size.

Data Collection Procedure

All methods were conducted in compliance with the Declaration of Helsinki guidelines. An ethical clearance letter was obtained from the department of internal medicine institutional review board. Informed verbal consent was obtained from each study participant before data collection. All participants included in this study were also informed that their data would be used as part of publications in anonymized form, to which they gave consent.

Using a pretested, structured questionnaire developed from the recent World Health Organization operational framework of SDOH, these were directly collected from patients by data collectors at the diabetic clinic during the study period. CKM disease, comorbid conditions, glycemic control, and type of diabetes were collected from electronic data using a medical record number. Data collectors had a day orientation by the principal investigator on how to collect data from patients and electronic data. All adult patients with diabetes at follow-up (new or existing, type 1 and type 2) in the diabetic follow-up clinic were included. Pregnant patients and patients with incomplete medical records were excluded.

CKM syndrome was defined as the presence of CVD and/or diabetic nephropathy in a patient with diabetes [20]. CVD includes the presence of heart failure, coronary heart disease, cerebrovascular disease, arrhythmia, cardiomyopathy, or peripheral artery disease [21]. Diabetic nephropathy is defined as a persistent elevation of urinary albumin excretion (urine albumin to creatinine ratio >30 mg/g or 24-hour urine protein >150 mg), low estimated glomerular filtration rate (<60 mL/min/1.73 m2), or other manifestations of kidney damage more for more than 3 months [22]. The inability to afford healthy foods was defined based on the ability to consistently afford meals meeting the plate method recommended by the American Diabetes Association. The plate method is composed of 50% vegetables (preferably nonstarchy vegetables), 25% carbohydrates (whole grains or other nutrient-dense options), and 25% protein (lean protein sources) [23].

Data Quality Control

Three medical students and one physician as supervisor were involved in collecting the data after undergoing 1 day of training by the principal investigator. A pretest was conducted on 5% of the sample size to check the consistency and the data completeness in the records. A few minor changes to the questionnaire were made based on the pretest results. The tool used in this study also underwent face validation by expert endocrinologists and public health specialists to ensure its appropriateness for our population and research objectives. The supervisor and principal investigator checked the information collected daily to ensure completeness and consistency.

Data Analysis

After data were checked manually for completeness and consistency, these were exported into SPSS version 29 software for further cleaning and analysis. Frequencies, percentages, and mean scores were computed in the descriptive statistics. Using bivariate analysis, independent variables were assessed for the association with CKM syndrome. The result is presented using tables, graphs, and text. Those independent variables with P values less than .2 were analyzed using multivariable logistic regression. The association was expressed as odds ratio with 95% CI and a P value of less than .05 was used as a statistically significant level for associations between dependent and independent variables.

Results

Demographic Information and Background Diabetes History

A total of 422 adult patients with diabetes were included in this study. The mean age of participants was 54.14 years. Most of the participants (95.02%) were from urban areas, 52.84% were male, 83.2% had type 2 diabetes or other specific causes, and almost two-thirds of the patients had hypertension (Table 1). The study participants are homogeneous, consisting of individuals of Black race. There is no relatively significant cultural variations among them as well.

Table 1.

Demographic information and background diabetes history of patients with diabetes on follow-up at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia

Variables Frequency Percentage
Sociodemographic characteristics
Age of participants Mean ± SD = 54.14 ± 13.74 min = 18 and max = 90
Age groups, y ≤45 115 27.3%
46-55 96 22.7%
56-65 117 27.7%
≥66 94 22.3%
Sex of participants Male 223 52.84%
Female 199 47.16%
Marital status Single 48 11.4%
Married 337 79.9%
Divorced or Widowed 37 8.8%
Residence Rural 21 4.98%
Urban 401 95.02%
Birth order First 131 31.0%
Middle 226 53.6%
Last 65 15.4%
Diabetes history
Type of diabetes Type 1 diabetes 71 16.8%
Type 2 diabetes or other specific causes 351 83.2%
Duration of diabetes, y <5 105 24.9%
5-9 76 18.0%
10-20 138 32.7%
>20 103 24.4%
Recent hemoglobin A1c level measured within past 3 mo ≤7 124 29.4%
7-10 203 48.1%
>10 95 22.5%
FBS control status Good FBS control 179 42.4%
Poor FBS control 243 57.6%
Hypertension Yes 264 62.6%
No 158 37.4%
Dyslipidemia Yes 143 33.9%
No 279 66.1%
Other comorbidities Yes 16 3.8%
No 406 96.2%

Abbreviations: FBS, fasting blood sugar; max, maximum; min, minimum.

Physical Environment and Economic Instability

Most of the patients (84.4%) have lived in their current house for more than 5 years. However, half (50.9%) of them have a high economic burden of a housing price-to-income of above 40%. Most of the patients (91.2%) have regular access to electricity and (74.9%) have a comfortable space for physical activity A significant number (41.9%) of patients could not afford to eat healthy food (Table 2).

Table 2.

Physical environment and economic instability of patients with diabetes on follow-up at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia

Variables Frequency Percentage
Physical environment
Housing status Own 291 69.0%
Rent 115 27.3%
Other or homeless 16 3.8%
Housing stability, y <5 66 15.6%
≥5 356 84.4%
Housing price-to-income ratio >40% Yes 207 49.1%
No 215 50.9%
Access to electricity? Yes 385 91.2%
No 37 8.8%
Natural or human-made disasters in past 1 y Yes 33 7.8%
No 389 92.2%
Comfortable space for physical activity Yes 316 74.9%
No 106 25.1%
Economic characteristics
Monthly income, ETB <2000 105 24.9%
2001-5000 145 34.4%
5001-9000 71 16.8%
>9000 101 23.9%
Skipped medication due to lack of money in past 1 y Yes 100 23.40
No 322 76.30
Lost to follow-up due to lack of money for >1 y Yes 35 8.3%
No 387 91.7%
Skipped renal, eye, or dental screening due to cost in past 1 y Yes 67 15.9%
No 355 84.1%
Could not afford to eat healthy food Yes 177 41.9%
No 245 58.1%
Employment status Employed 157 37.2%
Unemployed 116 27.5%
Retired 117 27.7%
Others 32 7.6%
Disabilities (extremity, vision or cognitive) Yes 93 22.0%
No 329 78.0%
Age <18 y children in family Yes 196 46.4%
No 226 53.6%
Family members with disabilities Yes 35 8.3%
No 387 91.7%
Older family members who are unable to work Yes 113 26.8%
No 387 91.7%

Abbreviation: ETB, Ethiopian birr.

Educational Status and Health Behaviors

Most of the patients (94.5%) have attended at least primary school and above. They can self-manage to take their medication (90.8%) and 95.5% can remember their hospital appointments. However, 70.6% of patients eat vegetables less than or equal to 3 days a week and 40% perform less than 150 minutes of moderate physical activity. The mean body mass index (BMI) of the patients was 26.47 (Table 3).

Table 3.

Educational status and health behaviors of patients with diabetes at follow-up at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia

Educational background
Level of education No formal education 23 5.5%
Primary school 87 20.6%
Secondary school 136 32.2%
Higher education 176 41.7%
Self-manage to take medications? Yes 383 90.8%
No 39 9.2%
Self-manage to remember their hospital appointments Yes 403 95.5%
No 19 4.5%
Basic diabetic self-management skills Yes 358 84.8%
No 64 15.2%
Health behaviors
How often do you eat vegetables? ≤3 d/wk 298 70.6%
>3 d/wk 124 29.4%
Minutes do you practice moderate physical activity <150 min 169 40.0%
>150 min 253 60.0%
Type of physical activity do you practice regularly Aerobics 331 78.4%
Aerobics and strengthening 20 4.7%
None 71 16.8%
What is your smoking history? Yes 61 14.5%
No 361 85.5%
Alcohol consumption history Never drinks alcohol 305 72.3%
<2 or 3 bottles/d for female and male patients, respectively 98 23.2%
>2 or 3 bottles/d for female and male patients, respectively 19 4.5%
BMI Mean ± SD = 26.47 ± 4.99, min = 16.07 and max 45.28
Normal/underweight (≤24.9) 175 41.5%
Overweight (25-29.9) 156 37.0%
Obese (≥30) 91 21.6%
Ever tried herbal or other traditional medication Yes 58 13.7%
No 364 86.3%

Abbreviation: BMI, body mass index.

Access to Health Care, Social Support, and Community Resources

Most patients (80.1%) have a glucometer and 87.7% have community-based health insurance. Almost two-thirds (63.3%) of the patients have follow-up in at least 2 departments. Eighty-seven percent of the patients did not have social support other than their family (Table 4).

Table 4.

Access to health care, social support, and community resources for patients with diabetes at follow-up at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia

Access to health care
Average out-of-pocket health care expenditure per mo <10% of your income 228 54.0%
10%-25% of your income 116 27.5%
>25% of your income 78 18.5%
Have glucometer Yes 338 80.1%
No 84 19.9%
Have health insurance Yes 370 87.7%
No 52 12.3%
Missed appointment due to lack of transport in past 1 y Yes 35 8.3%
No 387 91.7%
No. of outpatient department follow-up 1 155 36.7%
≥2 clinics 267 63.3%
Missed follow-up, too busy visiting several clinics in past 1 y Yes 24 5.7%
No 398 94.3%
Social support and community resources
Family support to treat their diabetes Yes 366 86.7%
No 56 13.3%
Health professionals in family Yes 123 29.1%
No 299 70.9%
Frequent religious places visit <1/wk 74 17.5%
1/wk 120 28.4%
>1/wk 228 54.0%
Social support other than family Yes 55 13.0%
No 367 87.0%
Loss of a family member by death in past 1 y Yes 65 15.4%
No 357 84.6%

Prevalence of Cardiovascular-Kidney-Metabolic Syndrome

More than half of patients (52.4%; 95% CI, 47.6%-56.9%) have CKM syndrome. Most of the patients have diabetic nephropathy (Fig. 1).

Figure 1.

Figure 1.

Percentage of each disease of cardiovascular kidney-metabolic syndrome among patients with diabetes at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia.

Social Determinants of Health for Cardiovascular-Kidney-Metabolic Syndrome

In the bivariable binary logistic analysis, sex, skipped medication due to lack of money in the past 1 year, lost to follow-up for more than a year due to lack of money, having a disability, level of education, self-manage to take medication, missed appointment due to lack of money in the past 1 year, family member death, age, hypertension, duration of diabetes, marital status, employment status, vegetable intake, smoking history, BMI, and type of diabetes were candidate variables for multivariable analysis. However, in the multivariable analysis, male sex, lost to follow-up for more than a year due to lack of money, disability, missed appointments due to lack of transportation in the past 1 year, hypertension, employment status, and BMI were significantly associated with CKM syndrome.

Keeping other variables constant, male patients with diabetes were nearly 2-fold (AOR: 1.73; 95% CI, 1.01-2.94) more at risk for CKM compared with their counterparts. Similarly, patients with diabetes who were lost to follow-up for more than a year due to lack of money (AOR: 2.69; 95% CI, 1.01-7.22) and missed appointments due to lack of transportation in the past 1 year (AOR: 2.98; 95% CI, 1.21-7.33) were more than 2 times at risk for CKM compared with the counterparts.

Patients with diabetes who have a disability were nearly 2 times (AOR: 1.97; 95% CI, 1.12-3.48) more at risk for CKM compared with individuals with no disability. Similarly, patients with diabetes having hypertension and obesity were more than 3- (AOR: 3.12; 95% CI, 1.85-5.28) and 2- (AOR: 2.27; 95% CI, 1.17-4.40) fold more at risk for CKM compared with their counterparts, respectively. Patients who retired were nearly 2 times (AOR: 2.12; 95% CI, 1.04-4.30) more at risk for CKM compared with those currently employed (Table 5).

Table 5.

Social determinants of health for cardiovascular-kidney-metabolic syndrome among patients with diabetes at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia

Variable CKM Crude odds ratio (COR) (95% CI) Adjusted odds ratio (AOR) (95% CI) P
Yes No
Sex Male 95 128 1.53 (1.04-2.25) 1.73 (1.01-2.94) .043a
Female 106 93 1 1
Age, y <45 79 36 1 1
45-55 38 58 3.34 (1.89-5.91) 2.08 (0.96-4.49) .060
56-65 53 64 2.65 (1.55-4.53) 0.89 (0.38-2.06) .795
>65 31 63 4.46 (2.48-7.99) 1.14 (0.43-3.03) .780
Educational level No formal education 6 17 1.24 (0.79-1.94) 1.43 (0.83-2.46) .189
Primary school 44 43 3.01 (1.11-8.08) 2.95 (0.89-9.73) .074
Secondary school 70 66 1.03 (0.60-1.77) 0.88(0.46-1.67) .707
≥College 81 95 1 1
Marital status Widowed/divorced 22 15 1.36 (0.56-3.31) 0.46 (0.15-1.41) .174
Married 147 190 2.58 (1.36-4.89) 1.04 (0.44-2.48) .916
Single 32 16 1 1
Skipped medication due to lack of money in past 1 y No 163 159 1 1
Yes 38 62 0.02 (1.67-1.05) 1.47 (0.84-2.57) .174
Lost to follow-up due to lack of money >1 y No 188 199 1
Yes 13 22 1.59 (0.78-3.26) 2.69 (1.01-7.22) .049a
Having disability No 172 157 1
Yes 29 64 2.41(1.48-3.94) 1.97(1.12-3.48) .019a
BMI Normal 92 83 1 1
Overweight 74 82 1.22 (0.79-1.89) 1.0(0.59-1.685) .999
Obese 35 56 1.77(1.05-2.97) 2.27(1.17-4.40) .015a
Self-manage to take medication No 12 27 2.19(1.07-4.45) 2.24 (0.91-5.53) .079
Yes 189 194 1 1
Missed appointment due to lack of transportation in past 1 y Yes 22 13 1.96 (0.96-4.01) 2.98(1.21-7.33) .017a
No 179 208 1 1
Family member death within 1 y No 176 181 1 1
Yes 25 40 1.55 (0.90-2.67) 1.83(0.96-3.46) .063
Hypertension No 105 53 1 1
Yes 96 168 3.46 (2.29-5.24) 3.12 (1.85-5.28) <.001a
Type of diabetes I 49 22 1 1
II 152 199 2.91 (1.69-5.03) 1.06 (0.43-2.61) .897
Duration of diabetes in year <5 56 49 1 .318
5-10 36 40 1.27(0.70-2.29) 1.52(0.75-3.08) .244
>10 109 132 1.38 (0.87-2.19) 1.53 (0.86-2.72) .147
Employment status Employed 90 67 1 1
Unemployed 56 60 1.43 (0.88-2.33) 1.36 (0.73-2.50) .322
Retired 42 75 2.39 (1.46-3.92) 2.12 (1.04-4.30) .037a
Other/Students 13 19 1.96 (0.90-4.253 2.19 (0.87-5.46) .093
Vegetable intake/wk ≤3 d 136 162 1.31 (0.86-1.99) 1.32 (0.80-2.16) .270
>3d 65 59 1 1
Smoking history Yes 24 37 1.48 (0.85-2.58) 1.12 (0.58-2.18) .726
No 177 184 1 1

Abbreviations: BMI, body mass index; CKM, cardiovascular-kidney-metabolic.

a Statistically significant association (P value <.05).

Discussion

Our finding revealed that more than half (52.4%; 95% CI, 47.6%-56.9%) of the individuals with diabetes among study participants had CKM syndrome. Our finding was higher than a study conducted in the United States that reported 26.3% of US adults between 2015 and 2020 have at least one CKM condition [24]. It is also higher than a study conducted in Israel in 2022 that showed that 12.63% of the patients had at least one condition within the diabetic cardiorenal spectrum [25]. This discrepancy might be due to lower socioeconomic status and a poor health-care setup, including limited medication availability, high patient-to-doctor ratios, inconsistent laboratory services, and associated late diagnosis in our study area. The other reason may be the inconsistent definitions and terms used in CKM syndrome. Furthermore, the frequency of chronic kidney disease (CKD) varies by race, with Black individuals having the highest prevalence due to high-risk genotypes such as APOL1, as demonstrated in ARIC and other research [26, 27]. This higher prevalence of CKM syndrome also implies that the diabetes is not well managed so it has progressed to a more advanced stage where multiple systems are affected. It underscores the need for integrated care that simultaneously addresses all aspects of the syndrome.

Our analysis reveals that male sex, loss of follow-up due to financial constraints, disability, missed appointments due to lack of transportation in the past 1 year, hypertension, employment status, and BMI are all significantly associated with CKM syndrome. Male patients with diabetes are more likely to acquire CKM syndrome, suggesting a sex difference in susceptibility to the illness [28]. This could be because estrogen has a cardiovascular protective effect in women, men have greater visceral obesity than women, and men have delayed health-care–seeking behavior [29, 30]. Except for a Saudi Arabian study [31], our finding is consistent with previous research indicating that men had a higher risk of cardiovascular and metabolic disorders [3, 32, 33].

The statistically significant association between loss to follow-up for more than a year due to lack of money and missed appointments due to transportation in the past 1 year due to issues with CKM syndrome proves the critical role of economic and logistical barriers in disease management. These findings are consistent with previous research that identifies financial constraints and access to transportation as substantial barriers to effective disease management and preventive care [2, 34]. This limited access to health-care facilities may lead to a lack of specialists and expert evaluation and a lack of better treatment, which may cause CKM disease. Patients with disabilities have nearly double the risk of CKM syndrome compared to those without disabilities, similar to other studies conducted in the United States [35]. Similarly, in a Korean study conducted between 2009 and 2019, the hazard ratio of disability for the occurrence of heart disease in people with diabetes increased significantly [36]. A retrospective study in China showed a higher incidence of coronary heart disease in the physical disability group compared to the non–physical disability group [37]. This could be explained by the fact that disabilities can limit access to health care, increase the risk of traditional cardiovascular risk factors, and make it difficult to manage chronic diseases, all of which contribute to their increased risk.

The prevalence of hypertension (62.6%) in this study was high, which emphasizes the need for integrated care approaches and public health interventions among patients with diabetes. The strong associations between hypertension and obesity with CKM syndrome also emphasize the role of these traditional risk factors similar to other studies conducted in Spain, Nigeria, and Ethiopia [38-41]. Both conditions are well-documented contributors to metabolic and cardiovascular syndromes, reinforcing the need for integrated management strategies that address these comorbidities [42]. Hypertension damages the endothelium of blood vessels, promoting inflammation and plaque formation, accelerates atherosclerosis, is linked to insulin resistance, and causes hypertensive nephrosclerosis [43]. Obesity also increases blood volume and cardiac output, RAAS-induced inflammation, and dyslipidemia [44]. However, it contradicts other studies that obesity has a protective effect [45, 46]. This difference may be due to more specific studies in CKD and heart failure patients only in those research studies.

Retired individuals are at nearly twice the risk for CKM syndrome compared to those currently employed. In retired individuals with diabetes, the combination of aging, longer duration of diabetes, changes in lifestyle like decreased physical activity, comorbidities like hypertension and dyslipidemia, and cumulative oxidative stress and inflammation all may contribute to an elevated risk of cardiovascular, kidney, and metabolic diseases. Proper management of diabetes, regular physical activity, dietary control, and monitoring of comorbid conditions are essential in reducing these risks. However, those complications alone might contribute to the early retirement of patients. In one study workers with CVD or diabetes had a significantly increased probability of early retirement [47].

Study Strengths and Limitations

Putting it all together, our research confirmed the statistically significant association between different SDOH and CKM diseases. It also strengthened the already established association of male sex, hypertension, and obesity as a risk for diabetes, CKD, and CVD. This study has the following limitations. The cross-sectional design restricts our ability to infer causality, and the reliance on self-reported data introduces potential biases. We also did not assess the different stages of CKM syndrome. However, this is the first study in Africa that has focused on SDOH and CKM diseases, which could be a baseline research for physicians and further researchers.

Conclusion

The prevalence of CKM syndrome among patients with diabetes was high. Being male, loss to follow-up for more than a year due to lack of money, missing appointments due to lack of transportation in the past 1 year, having a disability, presence of hypertension, being retired from work, and a BMI of 30 or greater increased risk of CKM syndrome.

Recommendation

For health-care providers in low- and middle-income countries, recognizing the increased risk associated with disability, financial constraints, and employment status can inform more tailored and supportive care strategies. The Ministry of Health and other nongovernmental organizations should address financial and logistical barriers through targeted support programs. Initiatives aimed at improving transportation options and financial assistance for health-care costs are crucial in mitigating these barriers. Future researchers investigating the effectiveness of interventions designed to address financial, logistical, and social barriers will be valuable in developing targeted strategies to prevent and manage CKM syndrome.

Acknowledgments

We are thankful to Addis Ababa University, College of Health Science, School of Medicine, Department of Internal Medicine, for sponsoring this research. The funder had no role in the design of the study, the collection, analysis, and interpretation of the data, nor in the writing of the manuscript. Our appreciation also goes to the data collectors and all participants in this study.

Abbreviations

ARIC

Atherosclerosis Risk in Communities

BMI

body mass index

CKD

chronic kidney disease

CKM

cardiovascular-kidney-metabolic

CVD

cardiovascular disease

RAAS

renin-angiotensin-aldosterone system

SDOH

social determinants of health

TASH

Tikur Anbessa Specialized Hospital

Contributor Information

Kibret Enyew Belay, Email: kibret.enyew@aau.edu.et, Department of Internal Medicine, Endocrinology and Metabolism Unit, Addis Ababa University, Addis Ababa 1000, Ethiopia.

Yeweyenhareg Feleke, Department of Internal Medicine, Endocrinology and Metabolism Unit, Addis Ababa University, Addis Ababa 1000, Ethiopia.

Theodros Aberra Alemneh, Department of Internal Medicine, Endocrinology and Metabolism Unit, Addis Ababa University, Addis Ababa 1000, Ethiopia.

Asteway Mulat Haile, Department of Internal Medicine, Addis Ababa University, Addis Ababa 1000, Ethiopia.

Dawit Girma Abebe, Department of Internal Medicine, Alert Specialized Hospital, Addis Ababa 1000, Ethiopia.

Funding

This study received funding support from Addis Ababa University.

Disclosures

The authors have nothing to disclose.

Data Availability

Data are available on request from the corresponding author.

References

  • 1. Mattina  A, Argano  C, Brunori  G, et al.  Clinical complexity and diabetes: a multidimensional approach for the management of cardiorenal metabolic syndrome. Nutr Metabol Cardiovasc Dis. 2022;32(12):2730‐2738. [DOI] [PubMed] [Google Scholar]
  • 2. Ndumele  CE, Rangaswami  J, Chow  SL, et al.  Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association. Circulation. 2023;148(20):1606‐1635. [DOI] [PubMed] [Google Scholar]
  • 3. Arnold  SV, Kosiborod  M, Wang  J, Fenici  P, Gannedahl  G, LoCasale  RJ. Burden of cardio-renal-metabolic conditions in adults with type 2 diabetes within the diabetes collaborative registry. Diabetes. Obe Metab. 2018;20(8):2000‐2003. [DOI] [PubMed] [Google Scholar]
  • 4. Suzuki  T, Agarwal  SK, Deo  R, et al.  Kidney function and sudden cardiac death in the community: the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J. 2016;180:46‐53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Wang  H, Li  N, Chivese  T, et al.  IDF diabetes atlas: estimation of global and regional gestational diabetes mellitus prevalence for 2021 by International Association of Diabetes in Pregnancy Study Group’s Criteria. Diabetes Res Clin Pract. 2022;183:109050. [DOI] [PubMed] [Google Scholar]
  • 6. Savira  F, Magaye  R, Liew  D, et al.  Cardiorenal syndrome: multi-organ dysfunction involving the heart, kidney and vasculature. Br J Pharmacol. 2020;177(13):2906‐2922. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Sattar  N, Lee  MM, Kristensen  SL, et al.  Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials. Lancet Diabetes Endocrinol. 2021;9(10):653‐662. [DOI] [PubMed] [Google Scholar]
  • 8. Cardoso  R, Graffunder  FP, Ternes  CM, et al.  SGLT2 inhibitors decrease cardiovascular death and heart failure hospitalizations in patients with heart failure: a systematic review and meta-analysis. EClinicalMedicine. 2021;36:100933. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Baigent  C, Landray  MJ, Reith  C, et al.  The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet. 2011;377(9784):2181‐2192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Vaduganathan  M, Filippatos  G, Claggett  BL, et al.  Finerenone in Heart Failure and Chronic Kidney Disease with Type 2 Diabetes: the FINE-HEART pooled analysis of cardiovascular, kidney, and mortality outcomes. Nat Med. 2024;24(4):1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Castagno  D, Jhund  PS, McMurray  JJ, et al.  Improved survival with bisoprolol in patients with heart failure and renal impairment: an analysis of the cardiac insufficiency bisoprolol study II (CIBIS-II) trial. Eur J Heart Fail. 2010;12(6):607‐616. [DOI] [PubMed] [Google Scholar]
  • 12. Gu  X, Jiang  S, Yang  Y, Li  W. Effects of finerenone and glucagon-like peptide 1 receptor agonists on cardiovascular and renal outcomes in type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetol Metab Syndr. 2024;16(1):14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Agarwal  R, Filippatos  G, Pitt  B, et al.  Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis. Eur Heart J. 2022;43(6):474‐484. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Mann  JF, Rossing  P, Bakris  G, et al.  Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial. Nat Med. 2024;30:2849‐2856. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Morales  J, Handelsman  Y. Cardiovascular outcomes in patients with diabetes and kidney disease: jACC review topic of the week. J Am Coll Cardiol. 2023;82(2):161‐170. [DOI] [PubMed] [Google Scholar]
  • 16. Fletcher  RA, Herrington  WG, Agarwal  R, et al.  Effects of SGLT2 inhibitors on cause-specific cardiovascular death in patients with chronic kidney disease: a meta-analysis of CKD progression trials. Clin J Am Soc Nephrol. 2024;19(9):1180‐1182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Marmot  M, Friel  S, Bell  R, Houweling  TA, Taylor  S. Closing the gap in a generation: health equity through action on the social determinants of health. The lancet. 2008;372(9650):1661‐1669. [DOI] [PubMed] [Google Scholar]
  • 18. He  J, Bundy  JD, Geng  S, et al.  Social, behavioral, and metabolic risk factors and racial disparities in cardiovascular disease mortality in US adults: an observational study. Ann Intern Med. 2023;176(9):1200‐1208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Jurkovitz  CT, Li  S, Norris  KC, et al.  Association between lack of health insurance and risk of death and ESRD: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2013;61(4):S24‐S32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Jaradat  JH, Nashwan  AJ. Cardiovascular-kidney-metabolic Syndrome: Understanding the Interconnections and the Need for Holistic Intervention. Elsevier; 2023:100028. [Google Scholar]
  • 21. Nabel  EG. Cardiovascular disease. N Engl J Med. 2003;349(1):60‐72. [DOI] [PubMed] [Google Scholar]
  • 22. American Diabetes Association Professional Practice Committee . 11. chronic kidney disease and risk management: standards of care in diabetes—2024. Diabetes Care. 2024;47(Supplement_1):S219‐S230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. American Diabetes Association Professional Practice Committee . 5. facilitating positive health behaviors and well-being to improve health outcomes: standards of care in diabetes—2024. Diabetes Care. 2024;47(Supplement_1):S77‐S110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Aggarwal  R, Ostrominski  JW, Vaduganathan  M. Prevalence of cardiovascular-kidney-metabolic syndrome stages in US adults, 2011-2020. JAMA. 2024;331(21):1858‐1860. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Schechter  M, Melzer Cohen  C, Yanuv  I, et al.  Epidemiology of the diabetes-cardio-renal spectrum: a cross-sectional report of 1.4 million adults. Cardiovasc Diabetol. 2022;21(1):104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Choi  Y, Jacobs  Jr  DR, Kramer  HJ, Shroff  GR, Chang  AR, Duprez  DA. Racial differences and contributory cardiovascular and non-cardiovascular risk factors towards chronic kidney disease progression. Vasc Health Risk Manag. 2023;19:433‐445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Doshi  MD, Li  L, Naik  AS, Thomas  CP. APOL1 kidney risk variants and long-term kidney function in healthy middle-aged black individuals: the Atherosclerosis Risk in Communities (ARIC) Study. Kidney Med. 2024;6(6):100828. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Goldberg  I, Krause  I. The role of gender in chronic kidney disease. Emj. 2016;1(2):58‐64. [Google Scholar]
  • 29. Shajahan  S, Amin  J, Phillips  JK, Hildreth  CM. Relationship between sex and cardiovascular mortality in chronic kidney disease: a systematic review and meta-analysis. PLoS One. 2021;16(7):e0254554. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Nakamura  T, Tokunaga  K, Shimomura  I, et al.  Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men. Atherosclerosis. 1994;107(2):239‐246. [DOI] [PubMed] [Google Scholar]
  • 31. Khan  AR, Lateef  ZNA-A, Fatima  S, Al Yousuf  SAA, Afghan  SZK, Al Marghani  S. Prevalence of chronic complication among type 2 diabetics attending primary health care centers of Al Ahsa district of Saudi Arabia: a cross sectional survey. Glob J Health Sci. 2014;6(4):245‐253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Mhundwa  W, Joubert  G, Mofokeng  TR. The prevalence of chronic kidney disease among type 2 diabetes mellitus patients in central South Africa. S Afr Fam Pract (2004). 2023;65(1):e1‐e6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Aberra  T, Feleke  Y, Tarekegn  G, Bikila  D, Melesse  M. Prevalence and associated factors of diabetic nephropathy at Tikur Anbessa Comprehensive Specialized University Hospital, Addis Ababa, Ethiopia. Af J Nephrol. 2022;25(1):35‐45. [Google Scholar]
  • 34. Syed  ST, Gerber  BS, Sharp  LK. Traveling towards disease: transportation barriers to health care access. J Community Health. 2013;38(5):976‐993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Pinsky  JL, Branch  LG, Jette  AM, et al.  Framingham disability study: relationship of disability to cardiovascular risk factors among persons free of diagnosed cardiovascular disease. Am J Epidemiol. 1985;122(4):644‐656. [DOI] [PubMed] [Google Scholar]
  • 36. Kim  K, Lee  H-Y, Shin  DW, Han  KD, Jung  JH, Park  J-H. Associations of disability with incidence, scientific reports. 2024 [preprint]. Doi: 10.21203/rs.3.rs-4302371/v1 [DOI]
  • 37. Wu  J, Wang  Y, Li  Y, et al.  Are physically disabled people at high risk of coronary heart disease among disabled population−evidence from 7.5-year retrospective cohort study. Ann Epidemiol. 2024;90:42‐48. [DOI] [PubMed] [Google Scholar]
  • 38. Pazos  F. Range of adiposity and cardiorenal syndrome. World J Diabetes. 2020;11(8):322‐350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Tabarés Seisdedos  R. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13‐27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Ukwamedua  HA, Iweka  F, Omote  V. Central obesity among an African type 2 diabetic population: prevalence and correlates. Obesity Medicine. 2020;18:100203. [Google Scholar]
  • 41. Regassa  LD, Tola  A, Ayele  Y. Prevalence of cardiovascular disease and associated factors among type 2 diabetes patients in selected hospitals of Harari region, eastern Ethiopia. Front Public Health. 2021;8:532719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Rossing  P, Hansen  TW, Kümler  T. Cardiovascular and non-renal complications of chronic kidney disease: managing risk. Diabetes Obes Metab. 2024;26(S6):13‐21. [DOI] [PubMed] [Google Scholar]
  • 43. Van Buren  PN, Toto  R. Hypertension in diabetic nephropathy: epidemiology, mechanisms, and management. Adv Chronic Kidney Dis. 2011;18(1):28‐41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Hall  JE, Crook  ED, Jones  DW, Wofford  MR, Dubbert  PM. Mechanisms of obesity-associated cardiovascular and renal disease. Am J Med Sci. 2002;324(3):127‐137. [DOI] [PubMed] [Google Scholar]
  • 45. Naderi  N, Kleine  C-E, Park  C, et al.  Obesity paradox in advanced kidney disease: from bedside to the bench. Prog Cardiovasc Dis. 2018;61(2):168‐181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Padwal  R, McAlister  FA, McMurray  JJ, et al.  The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data. Int J Obes. 2014;38(8):1110‐1114. [DOI] [PubMed] [Google Scholar]
  • 47. Kouwenhoven-Pasmooij  TA, Burdorf  A, Roos-Hesselink  JW, Hunink  MG, Robroek  SJ. Cardiovascular disease, diabetes and early exit from paid employment in Europe; the impact of work-related factors. Int J Cardiol. 2016;215:332‐337. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Data are available on request from the corresponding author.


Articles from Journal of the Endocrine Society are provided here courtesy of The Endocrine Society

RESOURCES